Clarametyx Biosciences Announces $33M Series A Financing To Advance Anti-Biofilm Biologics For Serious Bacterial Infections
Amount Raised
$33 Million
Round Type
Series A
ColumbusBiotechnologyHealth CareInvestors
Description
Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms, today announced the successful completion of a $33 million Series A round. The proceeds from the round will enable the company to accelerate efforts across its pipeline, including specifically to evaluate the potential of Clarametyx’s lead therapeutic candidate CMTX-101 to combat infection in people with cystic fibrosis (CF), a progressive, genetic disease that affects the lungs, pancreas and other organs.
Quick answer
Clarametyx Biosciences raised $33 Million in a Series A round, dated January 5, 2024. Investors: 1776 Fund, C Bio Investors, Jobs Ohio Growth Capital, Rev1 Ventures, Nationwide Children’s Hospital, Ohio Innovation Fund and Cf Foundation. Clarametyx Biosciences is based in Columbus, Ohio, United States.
- How much did Clarametyx Biosciences raise?
- Clarametyx Biosciences raised $33 Million in a Series A round on January 5, 2024.
- Who invested in Clarametyx Biosciences?
- 1776 Fund, C Bio Investors, Jobs Ohio Growth Capital, Rev1 Ventures, Nationwide Children’s Hospital, Ohio Innovation Fund and Cf Foundation are named as investors in this round.
- What does Clarametyx Biosciences do?
- Clarametyx Biosciences is combating the formidable challenge of chronic respiratory diseases through an innovative technology platform targeting the biofilm—a protective layer around bacteria that drives inflammation..
- Where is Clarametyx Biosciences based and how big is it?
- Clarametyx Biosciences is based in Columbus, Ohio, United States.
- Who are the decision-makers at Clarametyx Biosciences?
- Fundz holds 2 contacts at Clarametyx Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Clarametyx Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Biofrontera raised $8M on February 19, 2024.
- GlycanAge raised $4.2M (Seed) on February 19, 2024.
- XORTX Therapeutics raised $2.5M (Seed) on February 19, 2024.
- AIM ImmunoTech raised $3.3M (Seed) on February 16, 2024.
- Ultivue raised $22M (Series C) on February 16, 2024.
- valisure llc raised $4M (Seed) on February 16, 2024.
Who to call at Clarametyx Biosciences, and when
A new round usually means Clarametyx Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Clarametyx Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Clarametyx Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Clarametyx Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Clarametyx Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansClarametyx Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.